New front opens in battle against stroke

Medical scientists have vetted a potentially powerful new tool for helping prevent stroke and heart attack. In a study, researchers show that pioglitazone, a member of the insulin-sensitizing class of medications called thiazolidinediones, reduced the risk of stroke or heart attack by almost a quarter in patients who had previously suffered a stroke or mini-stroke.
Source: ScienceDaily Headlines - Category: Science Source Type: news

Related Links:

FRIDAY, March 27, 2020 -- With the new coronavirus severely straining the U.S. health care system, experts are calling on heart attack and stroke survivors to take extra steps to reduce their risk of a repeat event. The American Heart Association...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
ConclusionClopidogrel monotherapy was neither inferior nor superior to aspirin monotherapy for the secondary prevention of recurrent cerebrovascular attack following previous ischemic stroke in patients with T2DM. Hence, clopidogrel or aspirin monotherapy is equally safe and effective in these patients with T2DM.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
Authors: Aung AT, Chan SP, Kyaing TT, Lee CH Abstract Introduction: Compared to clinic blood pressure (BP), sleep-time BP and non-dipping BP pattern are better predictors of target organ damage and cardiovascular sequalae.Aim: In a retrospective study, we determined whether diabetes mellitus (DM) status is associated with high sleep-time BP and non-dipping pattern.Methods: We analyzed 1092 patients who underwent ambulatory BP monitoring between 2015 and 2017 in a tertiary cardiology institution. During a 24-hour period, BP was automatically measured every 15 minutes between 7:00 AM and 11:59 PM and every 30&nb...
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research
CAMBRIDGE (CBS) – Researchers at the Massachusetts Institute of Technology are working on an alternative treatment that can be used when a hospital runs out of ventilators. The researchers are testing whether a drug called TPA that is now used to treat blood clots in heart attack and stroke victims could also clear blood clots that form in the lungs of some people in respiratory failure. Doctors are planning to test this approach at Beth Israel Deaconess Medical Center and at a hospital in Colorado.
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Cambridge News Massachusetts Institute Of Technology Source Type: news
When Dr. Mark Lewis has to tell a cancer patient they’re dying, he tries to do so as compassionately as possible, usually offering a hug or a hand to hold. The thought of doing so by phone, he says, once felt heartbreakingly impersonal. But in the face of the current COVID-19 pandemic, the Salt Lake City-based gastrointestinal oncologist has had to do many things that make his “conscience weigh heavy.” He’s delivered bad news virtually, to limit the possibility of spreading the virus. He’s delayed chemotherapy for patients who—he hopes—can wait, knowing the treatment would wipe out...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Magazine Source Type: news
Thyroid, Ahead of Print.
Source: Thyroid - Category: Endocrinology Authors: Source Type: research
(CNN) — Ending your day with a hot bath might have more benefits than just relaxation. It could also lower your risk of heart disease and stroke, a new study finds. Previous research on bathing has already shown that it’s beneficial for sleep quality and how healthy a person thinks they are. A new study, published Tuesday in the journal Heart, found that a daily hot bath is also associated with a 28% lower risk of heart disease, and a 26% lower risk of stroke — likely because taking a bath is also associated with lowering your blood pressure, the researchers said. They discovered this after tracking the b...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston CNN Source Type: news
ConclusionAdjusting for imbalances in baseline variables that influence outcomes (or the response to therapy or both) can improve the power around the estimate of the effect of treatment and may alter its statistical significance. Along with the CHARM-Preserved results, these findings suggest that angiotensin-receptor blockers may have a modest effect in HFpEF.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research
AbstractIntroductionHematoma expansion (HE) after intracerebral hemorrhage (ICH) is associated with short-term mortality, but its impact on long-term prognosis is still unclear. The aim of this study was to evaluate the impact of HE on long-term survival and functional status after spontaneous ICH.MethodsConsecutive patients admitted with spontaneous ICH were prospectively enrolled and followed up for a minimum of 2  years. We compared short-term (
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Actos | Cardiology | Heart | Heart Attack | Insulin | Science | Stroke | Study